Spermidine alleviates thymopoiesis defects and aging of the peripheral T-cell population in mice after radiation

Kengo Yoshida1, Zhenqiu Liu2, Yoshiko Kubo1

  • 1Department of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima, Japan.

Experimental Gerontology
|December 6, 2024
PubMed

Insights

Ionizing radiation accelerates T cell aging, but spermidine (SPD) treatment may reverse these effects. SPD mitigated radiation-induced decreases in T cells and thymic cellularity, suggesting a potential rejuvenating effect.

Area of Science:

  • Immunology
  • Gerontology
  • Molecular Biology

Background:

  • T cell aging is influenced by genotoxic factors like ionizing radiation (accelerates) and metabolic controls like caloric restriction (retards).
  • Mechanisms underlying the interaction of systemic factors in T cell aging are not fully understood.

Purpose of the Study:

  • To investigate the effects of ionizing radiation and subsequent spermidine (SPD) treatment on the T cell pool, thymic cellularity, and transcriptome in mice.
  • To explore SPD's potential to counteract radiation-induced T cell aging.

Main Methods:

  • Mice were irradiated (3.8 Gy) at 5 weeks of age and treated with spermidine (30 mM) 13 months later.
  • Analysis included peripheral blood T cell counts (CD4, CD8, virtual memory), thymic cellularity, and thymus RNA sequencing.

Main Results:

  • Irradiation decreased conventional T cells but increased virtual memory T cells; SPD treatment negated these changes.
  • Irradiation reduced thymocyte numbers, while SPD treatment prevented this reduction.
  • RNA sequencing revealed radiation-induced upregulation of inflammatory genes, largely reversed by SPD treatment.

Conclusions:

  • Spermidine may alleviate radiation-induced acceleration of T cell aging by preserving thymopoiesis and reducing inflammation.
  • Further research is needed to confirm SPD's rejuvenating potential and elucidate its mechanisms in accelerated T cell aging.